This inventor holds 1 USPTO granted patent and 14 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations of Jonas Vikesaa
Introduction
Jonas Vikesaa is a notable inventor based in Fredensborg, Denmark. He has made significant contributions to the field of molecular biology, particularly in the development of antisense oligonucleotides. His work focuses on addressing challenges related to RNA binding protein function.
Latest Patents
Jonas Vikesaa holds a patent for "Oligonucleotides targeting RNA binding protein sites." This invention relates to antisense oligonucleotides that are complementary to conserved TDP-43 binding sites on pre-mRNA transcripts. These oligonucleotides are capable of restoring RNA binding protein function in the processing of multiple independent mRNAs in TDP-43 depleted cells. He has 1 patent to his name.
Career Highlights
Jonas is currently employed at Hoffmann-La Roche Inc., where he continues to advance his research and innovations. His work has implications for understanding and potentially treating diseases associated with TDP-43, which is crucial in neurodegenerative conditions.
Collaborations
Throughout his career, Jonas has collaborated with esteemed colleagues, including Christian Weile and Martin Ebeling. These partnerships have fostered a productive research environment, enhancing the impact of their collective work.
Conclusion
Jonas Vikesaa's contributions to the field of molecular biology through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in understanding RNA binding proteins and their functions.